Joseph Ayoub

3.2k total citations
26 papers, 1.1k citations indexed

About

Joseph Ayoub is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Joseph Ayoub has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Joseph Ayoub's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Joseph Ayoub is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Joseph Ayoub collaborates with scholars based in Canada, United States and France. Joseph Ayoub's co-authors include Richard L. Momparler, David Y. Bouffard, Louise F. Momparler, Yvon Cormier, Frances A. Shepherd, Francis Laberge, E. Eisenhauer, David J. Stewart, Richard Gregg and Lesley Seymour and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Joseph Ayoub

26 papers receiving 1.0k citations

Peers

Countries citing papers authored by Joseph Ayoub

Since Specialization

Citations

This map shows the geographic impact of Joseph Ayoub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Ayoub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Ayoub more than expected).

Fields of papers citing papers by Joseph Ayoub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Ayoub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Ayoub. The network helps show where Joseph Ayoub may publish in the future.

Co-authorship network of co-authors of Joseph Ayoub

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Ayoub. A scholar is included among the top collaborators of Joseph Ayoub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Ayoub. Joseph Ayoub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Features and Course of Brain Metastases in Colorectal Cancer: An Experience from a Single Institution 2012 ·Current Oncology ·(unknown), Joseph Ayoub, Bernard Lemieux, F. Aubin, Walid Saliba, Marie‐Pierre Campeau, (unknown)	68
2	Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21 2006 ·Journal of Clinical Oncology ·Andrea Bezjak, Dongsheng Tu, Lesley Seymour, Gary M. Clark, (unknown), Mauro Zukin, Joseph Ayoub, (unknown), Ronaldo de Albuquerque Ribeiro, Alexandra Gerogianni, Arnold Cyjon, Jonathan Noble, Francis Laberge, (unknown), David Fenton, Joachim von Pawel, Martin Reck, Frances A. Shepherd	239
3	Phase II trial with carboplatin/gemcitabine (Cb/G) induction chemotherapy (CT) followed by radiotherapy concomitantly with paclitaxel/gemcitabine (P/G) in stage III non small cell lung cancer (NSCLC): Preliminary report 2005 ·Journal of Clinical Oncology ·Vera Hirsh, Marie Duclos, Pierre Del Vecchio, Linda Ofiara, Joseph Ayoub, Sergio Faria, Danielle Charpentier, Lorraine Portelance, Luís Souhami, Denis Soulières	1
4	Phase II Study of Troxacitabine (BCH-4556) in Patients with Advanced Non-Small-Cell Lung Cancer 2005 ·Lung ·Susan Dent, Andrew Arnold, (unknown), S. Gertler, Joseph Ayoub, Gerald Batist, Glenwood Goss, (unknown), Denis Soulières, Jacques Jolivet, (unknown), Lesley Seymour	7
5	Weekly paclitaxel and gemcitabine chemotherapy for metastatic non‐small cell lung carcinoma (NSCLC) 2003 ·Cancer ·Vera Hirsh, Renaud Whittom, Linda Ofiara, P. Desjardins, Joseph Ayoub, Danielle Charpentier, David Small, Javier Pintos, Adrian Langleben	10
6	A Quebec Survey of Issues in Cancer Pain Management 2002 ·Journal of Pain and Symptom Management ·Neil Macdonald, Joseph Ayoub, (unknown), (unknown), Pauline Lesage, Nancy E. Mayo	26
7	Evaluation of an Inhibitor of DNA Methylation, 5-aza-2′-Deoxycytidine, for The Treatment of Lung Cancer and the Future Role of Gene Therapy 2002 ·Advances in experimental medicine and biology ·Richard L. Momparler, Nicoletta Eliopoulos, Joseph Ayoub	25
8	Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma 2001 ·Cancer ·Vera Hirsh, Adrian Langleben, Joseph Ayoub, Yvon Cormier, Javier Pintos, (unknown)	16
9	Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer 2001 ·Lung Cancer ·Richard L. Momparler, Joseph Ayoub	78
10	Placebo-Controlled Trial of 13-cis-Retinoic Acid Activity on Retinoic Acid Receptor-Beta Expression in a Population at High Risk: Implications for Chemoprevention of Lung Cancer 1999 ·Journal of Clinical Oncology ·Joseph Ayoub, (unknown), Yvon Cormier, David H. Meyer, Yun Ying, Philippe Major, Catherine Desjardins, W. E. C. Bradley	44
11	Pilot phase l-ll study on 5-aza-2??-deoxycytidine (Decitabine) in patients with metastatic lung cancer 1997 ·Anti-Cancer Drugs ·Richard L. Momparler, David Y. Bouffard, Louise F. Momparler, (unknown), (unknown), Joseph Ayoub	178
12	Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group 1996 ·Lung Cancer ·Jean Viallet, David J. Stewart, F. Shepherd, Joseph Ayoub, Yvon Cormier, (unknown), W.P. Steward	17
13	Cost Utility of Chemotherapy and Best Supportive Care in Non-Small Cell Lung Cancer 1995 ·PharmacoEconomics ·Wendy Kennedy, Daniel Reinharz, Geneviève Tessier, André‐Pierre Contandriopoulos, (unknown), François Champagne, Joseph Ayoub	26
14	Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC) 1994 ·Annals of Oncology ·Yvon Cormier, E. Eisenhauer, A. Muldal, Richard Gregg, Joseph Ayoub, Glen Goss, David J. Stewart, (unknown), D. C. T. Wong	123
15	Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer 1994 ·International Journal of Radiation OncologyBiologyPhysics ·Peter Coy, D. Ian Hodson, Nevin Murray, (unknown), David G. Payne, Andrew Arnold, Edmund Kostashuk, Peter Dixon, William K. Evans, Benny Zee, Anna Sadura, Joseph Ayoub, (unknown), Rafal Wierzbicki, Ronald Feld, Jean A. Maroun, Kenneth A. Wilson	17
16	Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer. 1990 ·Journal of Clinical Oncology ·William K. Evans, E. Eisenhauer, Yvon Cormier, Joseph Ayoub, Ryszard Wierzbicki, Francis Laberge, F. Shepherd	26
17	Vaginal intraepithelial neoplasia 1990 ·Gynecologic Oncology ·(unknown), G. Body, (unknown), Pierre Drouin, Joseph Ayoub	46
18	DNA alterations at proto-oncogene loci and their clinical significance in operable non-small cell lung cancer 1990 ·Cancer ·(unknown), (unknown), Edward C. Bradley, (unknown), Joseph Ayoub	12
19	VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group 1988 ·British Journal of Cancer ·William K. Evans, E. A. Eisenhauer, Peter Hughes, Jean A. Maroun, Joseph Ayoub, Frances A. Shepherd, Ronald Feld	32
20	5-Fluorouracil-metronidazole combination therapy in metastatic colorectal cancer 1986 ·Cancer Chemotherapy and Pharmacology ·(unknown), Jacques Jolivet, Yves Langelier, Jean‐Guy Besner, Joseph Ayoub	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact